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Background
Amyloid b (Ab) peptides, the primary constituents of
senile plaques and a hallmark in Alzheimer’s disease
pathology, are generated through the sequential cleavage
of amyloid precursor protein (APP) by BACE1 and
g-secretase. Evidence is accumulating that the early endo-
some constitutes a major compartment for APP proces-
sing; however, the mechanisms of how BACE1 encounters
APP are largely unknown.
Methods
HeLa cells are widely used as cellular models to unravel
transport itineraries as they are extremely well character-
ized and suited for both biochemical and imaging studies.
Major findings are extrapolated to primary neurons to
demonstrate that newly revealed regulatory mechanisms
are conserved in neurons and hence relevant in the light
of neurodegeneration. Studies are performed on endogen-
ous proteins as well as through overexpression using
either wt or fluorescently-tagged constructs in combina-
tion with dominant mutants of small GTPases to block
selective transport routes.
Results
Co-expression of either BACE1 or APP with RAB5-Q79L,
a GTP-locked RAB5 mutant, results in their entrapment
in enlarged endosomes. b-Cleaved ectodomain fragments
of APP accumulate in the lumen of these endosomes, as
this accumulation could be prevented by BACE1 inhibitors
or is absent in BACE1-/- fibroblasts transfected with
RAB5-Q79L. Blocking clathrin-mediated internalization
using siRNA against AP-2 complexes or mutant AP180,
affected strongly APP endocytosis while BACE1 internali-
zation persisted. Hence, in contrast to APP internalization
which is clathrin-dependent, we demonstrate that BACE1
is sorted to early endosomes via an alternative route con-
trolled by the small GTPase ARF6. Indeed, blocking this
route with a GTP-locked ARF6-Q67L mutant prevented
BACE1, but not APP, from reaching early endosomes.
Altering ARF6 levels or activity affects therefore endoso-
mal sorting of BACE1, and consequently results in altered
APP processing and Ab production. Furthermore, sorting
of newly internalized BACE1 from ARF6-positive towards
RAB5-positive early endosomes depends on its carboxy-
terminal DISLL motif. In primary hippocampal neurons,
endogenous ARF6 essentially localizes to soma and den-
drites, underscoring that this ARF6-mediated sorting of
BACE1 is confined to the somatodendritic compartment.
Using dual-microfluidic chambers, in which axons can be
physically separated from dendrites, we could demonstrate
that major BACE1-mediated ectodomain shedding and
secretion of amyloid b peptides occurs primarily in soma-
todendritic compartments.
Conclusion
Taken together, we conclusively demonstrate that BACE1
reaches the early endosomal compartment through a
mechanism mediated by ARF6, which is principally dis-
tinct from the clathrin-dependent route operated by APP.
Our study therefore demonstrates that BACE1 and the
APP can be independently sorted by interfering with the
expression and/or activity of regulatory proteins in the
respective endosomal-sorting machineries. Among these
are coat proteins as well as small GTPases and their acti-
vating/deactivating components. These findings pave the
way for researchers to identify factors or compounds that
selectively affect the endocytic sorting and recycling of
either BACE1 or APP, allowing for the development of
therapies that reduce the production of neurotoxic Ab in
the brain. As such, this study harbors a largely unexplored
therapeutic potential for Alzheimer’s disease.
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